FrancophonIA/ELRC3.0 huggingface dataset:
English: In the first two studies in a total of 997 patients, after 16 weeks of treatment around 75% of patients receiving Skyrizi had a reduction of at least 90% in PASI scores (a measure of how severe and widespread the skin lesions are), compared with around 45% of those receiving ustekinumab and around 4% of those receiving placebo.
Croatian: U prva dva ispitivanja na ukupno 997 bolesnika, nakon 16 tjedana liječenja kod otprilike 75 % bolesnika koji su primali Skyrizi zabilježeni su niži rezultati PASI od barem 90 % (mjerilo ozbiljnosti i raširenosti lezija na koži), u usporedbi s oko 45 % u bolesnika koji su primili ustekinumab te oko 4 % onih koji su primili placebo.
English: How does Skyrizi work?
Croatian: Kako djeluje Skyrizi?
English: What benefits of Skyrizi have been shown in studies?
Croatian: Koje su koristi od lijeka Skyrizi utvrđene u ispitivanjima?
English: At week 52, more patients who remained on Skyrizi had had clear or almost clear skin than those who were switched to placebo.
Croatian: Nakon 52 tjedna više bolesnika koji su primali Skyrizi imalo je čistu ili skoro čistu kožu u usporedbi s bolesnicima koji su prebačeni na placebo.
English: In addition, around 86% of patients receiving Skyrizi had clear or almost clear skin, compared with around 62% of those receiving ustekinumab and around 6% of those receiving placebo.
Croatian: Osim toga, oko 86 % bolesnika koji su primali Skyrizi imalo je čistu ili skoro čistu kožu u usporedbi s oko 62 % bolesnika koji su primali ustekinumab i 6 % onih koji su primali placebo.
English: In the third study involving 605 patients, after 16 weeks of treatment 72% of patients receiving Skyrizi had a reduction of at least 90% in PASI scores, compared with 47% of those receiving adalimumab.
Croatian: U trećem ispitivanju na 605 bolesnika, nakon 16 tjedana liječenja kod 72 % bolesnika koji su primili Skyrizi zabilježeni su niži rezultati PASI od barem 90 % u usporedbi s 47 % u bolesnika koji su primali adalimumab.
English: In addition, 84% of patients receiving Skyrizi had clear or almost clear skin, compared with 60% of those receiving adalimumab.
Croatian: Osim toga, 84 % bolesnika koji su primali Skyrizi imalo je čistu ili skoro čistu kožu u usporedbi s oko 60 % bolesnika koji su primali adalimumab.
English: Finally, in the fourth study involving 507 patients, after 16 weeks of treatment 73% of patients receiving Skyrizi had a reduction of at least 90% in PASI scores, compared with 2% of those receiving placebo.
Croatian: Konačno, u četvrtkom ispitivanju koje je uključivalo 507 bolesnika, nakon 16 tjedana liječenja kod 73 % bolesnika koji su primali Skyrizi zabilježeni su niži rezultati PASI od barem 90 % u usporedbi s 2 % bolesnika koji su primali placebo.
English: Other information about Skyrizi
Croatian: Ostale informacije o lijeku Skyrizi
English: Around 84% of patients receiving Skyrizi had clear or almost clear skin, compared with around 7% of those receiving placebo.
Croatian: Kod oko 84 % bolesnika koji su primali Skyrizi imalo je čistu ili skoro čistu kožu u usporedbi s oko 7 % bolesnika koji su primali placebo.
English: Skyrizi contains the active substance risankizumab.
Croatian: Skyrizi sadrži djelatnu tvar risankizumab.
English: How is Skyrizi used?
Croatian: Kako se Skyrizi primjenjuje?
English: Pharmaceutical form
Croatian: Farmaceutski oblik
English: (Invented) name Strength
Croatian: (Zaštićeno) ime
English: ATC vet code: QI07AD04.
Croatian: ATCvet kod: QI07AD04.
English: Such reactions may evolve to a more severe condition, which may be life-threatening.
Croatian: Takve reakcije mogu prerasti u teže stanje koje može biti opasno po život.
English: Can be used during the second and third stages of pregnancy.
Croatian: Može se primjenjivati tijekom druge i treće faze graviditeta.
English: If protection against rabies is required:
Croatian: Ako je potrebna zaštita od bjesnoće:
English: EXP {month/year} Once reconstituted, use immediately.
Croatian: EXP {mjesec/godina} Jednom rekonstituiran, odmah upotrijebiti.
English: Komenského 212, 683 23 Ivanovice na Hané, CZECH REPUBLIC
Croatian: Komenského 212, 683 23 Ivanovice na Hané, ČEŠKA REPUBLIKA
English: Store and transport refrigerated (2 °C - 8 °C).
Croatian: Čuvati i prevoziti na hladnom (2 °C - 8 °C).
English: If such a reaction occurs, appropriate treatment should be administered without delay.
Croatian: Ako dođe do takve reakcije, potrebno je odmah primijeniti odgovarajuće liječenje.
English: Date of last renewal: 27/03/2019.
Croatian: Datum posljednjeg produljenja odobrenja: 27/03/2019.
English: Use immediately after reconstitution.
Croatian: Odmah upotrijebiti nakon rekonstitucije.
English: A good immune response is reliant on a fully competent immune system.
Croatian: Dobar imunološki odgovor u potpunosti ovisi o sposobnosti imunološkog sustava.
English: Subcutaneous use.
Croatian: Subkutana upotreba.
English: Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIUM
Croatian: Zoetis Belgium SA Rue Laid Burniat 1 1348 Louvain-la-Neuve BELGIJA
English: Safety of the product during the early stage of pregnancy and during lactation have not been investigated.
Croatian: Nije ispitana sigurnost proizvoda tijekom rane faze graviditeta kao ni tijekom laktacije.
English: Do not mix with any veterinary medicinal products except those mentioned in section 4.8.
Croatian: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim onima navedenim u odjeljku 4.8.
English: EXPIRY DATE EXP {month/year}
Croatian: ROK VALJANOSTI EXP {mjesec/godina}
English: Do not use this veterinary medicinal product after the expiry date which is stated on the label after EXP.
Croatian: Ne koristite ovaj veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na etiketi poslije EXP.
English: This can be painful, warm or reddened.
Croatian: To može biti bolno, temperirano i zacrvenjeno.
English: Any such swelling will either have spontaneously resolved or be greatly diminished by 14 days after vaccination.
Croatian: Takve otekline će se ili spontano povući ili znatno smanjiti do 14 dana nakon cijepljenja.
English: However, in field studies 10% of seronegative dogs did not show seroconversion (>0.1 IU/ml) 3-4 weeks after single primary vaccination against rabies.
Croatian: Međutim, u terenskom ispitivanju 10% seronegativnih pasa nije pokazalo serokonverziju (> 0,1 IU/ml) 3 - 4 tjedna nakon prvog osnovnog cijepljenja protiv bjesnoće.
English: − 3 weeks after completion of the primary course for CPiV.
Croatian: - 3 tjedna nakon završetka osnovnog cijepljenja za CPiV.
English: − 3 weeks after the first vaccination for CDV, CAV, CPV, and
Croatian: Početak imunosti: - 3 tjedna nakon prvog cijepljenja za CDV, CAV, CPV, i
English: * Tissue culture infectious dose 50%.
Croatian: * 50 % infektivne doze kulture tkiva.
English: Lyophilisate (live attenuated):
Croatian: Liofilizat (živi, atenuirani):
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Croatian: Učestalost nuspojava je određena sukladno sljedećim pravilima: - vrlo česte (više od 1 na 10 tretiranih životinja pokazuju nuspojavu(e)), - česte (više od 1 ali manje od 10 životinja na 100 tretiranih životinja), - manje česte (više od 1 ali manje od 10 životinja na 1.000 tretiranih životinja), - rijetke (više od 1 ali manje od 10 životinja na 10.000 tretiranih životinja), - vrlo rijetke (manje od 1 životinje na 10.000 tretiranih životinja, uključujući izolirane slučajeve).
English: Solvent: clear colourless liquid.
Croatian: Otapalo: bistra bezbojna tekućina.
English: A single dose of Versican Plus DHPPi should be given every 3 years.
Croatian: Jednu dozu Versican Plus DHPPi treba primjenjivati svake tri godine.
English: Anorexia and decreased activity are rarely observed.
Croatian: U rijetkim slučajevima mogu se opaziti anoreksija i smanjena aktivnost
English: Immunocompetence of the animal may be compromised by a variety of factors including poor health, nutritional status, genetic factors, concurrent drug therapy and stress.
Croatian: Imunokompetencija životinje može biti ugrožena zbog raznih čimbenika uključujući loše zdravstveno stanje, gojno stanje, genetske čimbenike, usporednu terapiju drugim lijekovima i stres.
English: If you notice any side effects, even those not already listed in this package leaflet or you think that the medicine has not worked, please inform your veterinary surgeon.
Croatian: Ako zamijetite bilo koju nuspojavu ili druge nuspojave koje nisu opisane u uputi o VMP ili mislite da VMP nije djelovao, molimo obavijestite svog veterinara.
English: Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local requirements.
Croatian: Bilo koji neupotrebljeni veterinarsko-medicinski proizvod ili otpadni materijali dobiveni primjenom ovog veterinarsko-medicinskog proizvoda trebaju se odlagati u skladu s lokalnim propisima.
English: Incompatibilities: Do not mix with any other veterinary medicinal product other than those mentioned above.
Croatian: Inkompatibilnosti: Ne miješati s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim onima navedenim u gornjem tekstu.
English: However, due to the low pathogenicity of these strains, it is not necessary to keep vaccinated dogs separated from nonvaccinated dogs and domestic cats.
Croatian: Međutim, zbog niske patogenosti ovih sojeva, nije potrebno držati cijepljene pse odvojene od pasa koji nisu cijepljeni i domaćih mačaka.
English: Name and address of the manufacturer of the biological active substances
Croatian: Naziv i adresa proizvođača biološki djelatne tvari
English: At least one year following the primary vaccination course for canine parainfluenza virus.
Croatian: Najmanje godinu dana nakon osnovnog cijepljenja za pseći parainfluenza virus.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 04/07/2014.
Croatian: Datum prvog odobrenja: 04/07/2014.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE BOX
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU KUTIJA
English: Shelf life after reconstitution according to directions: use immediately.
Croatian: Rok valjanosti poslije rekonstitucije prema uputi: upotrijebiti odmah.
English: No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product other than Versiguard Rabies and Versican Plus L4.
Croatian: Ne postoje dostupni podaci o neškodljivosti i učinkovitosti ovog cjepiva kada se primjenjuje s bilo kojim drugim veterinarsko-medicinskim proizvodom, osim s Versiguard Rabies i Versican Plus L4.
English: The visual appearance is as follows:
Croatian: Vizualni izgled:
English: Some animals may also not show titres > 0.5 IU/ml after the primary vaccination.
Croatian: Moguće je da neke životinje neće pokazivati titar > 0,5 IU/ml nakon primarnog cijepljenja.
English: Annual re-vaccination is required for Parainfluenza, therefore a single dose of compatible vaccine Versican Plus Pi can be used annually as required.
Croatian: Godišnje docjepljivanje potrebno je za parainfluencu, stoga se pojedinačna doza kompatibilnog cjepiva Versican Plus Pi može primjenjivati godišnje prema potrebi.
English: Antibody titres drop over the course of the 3-year duration of immunity, although dogs are protected when challenged.
Croatian: Titar antitijela pada tijekom 3-godišnjeg trajanja imunosti, iako su psi bili zaštićeni u testovima izazivačke infekcije.
English: The mixed vaccines should be injected immediately via the subcutaneous route.
Croatian: Pomiješana cjepiva treba odmah subkutano primijeniti.
English: THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
Croatian: 13. RIJEČI “SAMO ZA PRIMJENU NA ŽIVOTINJAMA” I UVJETI ILI OGRANIČENJA U POGLEDU OPSKRBE I PRIMJENE,
English: Systemic reactions such as lethargy, hyperthermia and general malaise may occur very rarely.
Croatian: Vrlo rijetko su moguće sustavne reakcije poput letargije, hipertermije i opće malaksalosti.
English: Solve nt: Water for injections (Aqua ad iniectabilia)
Croatian: Voda za injekcije (Aqua ad iniectabilia)
English: Solvent: Water for injections
Croatian: Voda za injekcije
English: A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
Croatian: Odluku o primjeni ovog cjepiva prije, odnosno poslije primjene bilo kojeg drugog veterinarskomedicinskog proizvoda treba donositi od slučaja do slučaja.
English: Hypersensitivity reactions (e.g. gastrointestinal signs such as diarrhoea and vomiting, anaphylaxis, angioedema, dyspnoea, circulatory shock, collapse) may occur rarely.
Croatian: U rijetkim slučajevima moguće su reakcije preosjetljivosti (npr. gastrointestinalni znakovi, poput proljeva i povraćanja, anafilaksa, angioedem, dispneja, cirkulacijski šok, kolaps).
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Each dose of 1 ml contains:
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Svaka doza od 1 ml sadržava:
English: 50 x 1 dose
Croatian: 25 x 1 doza 50 x 1 doza
English: Immunological responses to the CDV, CAV and CPV components of the vaccine may be delayed due to maternally derived antibody interference.
Croatian: Imunološki odgovori na CDV, CAV i CPV komponente cjepiva mogu biti odgođene zbog interferencije s majčinskim protutijelima.
English: The vaccine virus strain CPV-2b has not been tested in other carnivores (except dogs and domestic cats) that are known to be susceptible to canine parvoviruses and therefore vaccinated dogs should be separated from them after vaccination.
Croatian: Cjepni virus soja CPV-2b nije testiran na ostalim mesojedima (osim pasa i domaćih mačaka), za koje se zna da su osjetljivi na pseći parvovirus i zbog toga bi cijepljene pse nakon cijepljenja trebalo držati odvojeno.
English: Rabies:
Croatian: Bjesnoća:
English: MARKETING AUTHORISATION NUMBER(S) EU/2/14/169/001
Croatian: BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET EU/2/14/169/001
English: In case of travelling to risk areas or outside the EU, veterinary surgeons may wish to give additional rabies vaccinations after 12 weeks of age to ensure that the vaccinated dogs have an antibody titre of ≥ 0.5 IU/ml, which is generally regarded as sufficiently protective and that they meet the travel test requirements (antibody titres ≥ 0.5 IU/ml).
Croatian: U slučajevima putovanja u rizična područja ili izvan EU-a, veterinari mogu zatražiti da se provedu dodatna cijepljenja protiv bjesnoće nakon navršenih 12 tjedana starosti kako bi se osiguralo da cijepljeni psi imaju titar antitijela od ≥ 0,5 IU/ml, koji se u pravilu smatra dovoljnom zaštitom, te da psi ispunjavaju zahtjeve testa za putovanja (titar antitijela ≥ 0,5 IU/ml).
English: The efficacy of the rabies fraction is proven after a single dose from 12 weeks of age in laboratory studies.
Croatian: Učinkovitost frakcije bjesnoće je dokazana u laboratorijskom ispitivanju nakon 12 tjedna starosti.
English: Minimum Maximum
Croatian: Minimalno
English: Lyophilisate: spongy matter of white colour.
Croatian: Liofilizat: spužvasta tvar bijele boje.
English: In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Croatian: U slučaju da se nehotice samo injicira, odmah potražiti pomoć liječnika i pokazati mu uputu o VMP ili etiketu.
English: However, the vaccine has been proven to be protective against virulent challenge in the presence of maternally derived antibodies to CDV, CAV and CPV at levels equal or higher to those likely to be encountered under field conditions.
Croatian: Međutim, za cjepivo je dokazano da je zaštitno u slučaju izlaganja zarazama u prisustvu majčinskih protutijela na CDV, CAV i CLV na istim ili višim razinama od onih koji se očekuju u terenskim uvjetima.
English: Protective immune response against CAV-2 associated respiratory disease is considered to last at least 3 years.
Croatian: Zaštitni imuni odgovor na pseći adenovirus tip 2 povezan s dišnom bolesti smatra se da traje najmanje 3 godine.
English: A transient swelling (up to 5 cm) may commonly be observed at the injection site following subcutaneous administration in dogs.
Croatian: Na mjestu primjene injekcije često se može opaziti prolazna oteklina (do 5 cm) nakon subkutane primjene u pasa.
English: Dosage and route of administration:
Croatian: Doza i put primjene:
English: The vaccine is intended for the active immunisation of healthy puppies and dogs against diseases caused by canine distemper virus, canine parvovirus, canine adenovirus Types 1 and 2, and canine parainfluenza virus.
Croatian: Cjepivo je namijenjeno za aktivnu imunizaciju zdrave štenadi i zdravih pasa protiv bolesti uzrokovanih virusom štenećaka, psećim parvovirusom, psećim adenovirusom tip 1 i 2 i psećim parainfluenca virusom.
English: SPECIAL STORAGE CONDITIONS Store and transport refrigerated.
Croatian: 11. POSEBNI UVIJETI ČUVANJA Čuvati i prevoziti na hladnom.
English: First dose: Versican Plus DHPPi from 8-9 weeks of age.
Croatian: Prva doza: Versican Plus DHPPi nakon navršenih 8 - 9 tjedna starosti.
English: However, in a minority of animals pain was observed at the injection site immediately after administration of a 10-fold overdose of the vaccine.
Croatian: Međutim, kod manjeg broja pasa uočena je bolnost na mjestu aplikacije odmah po primjeni deseterostruke doze.
English: Canine distemper virus, strain CDV Bio 11/A
Croatian: Virus štenećaka, soj CDV Bio 11/A
English: INDICATION(S) Read the package leaflet before use.
Croatian: INDIKACIJA(E) Pročitati uputu o VMP prije primjene.
English: Canine adenovirus Type 2
Croatian: Pseći adenovirus tip 2
English: Pack sizes:
Croatian: Veličine pakovanja:
English: The duration of immunity against CAV-2 was not established by challenge.
Croatian: Trajanje imuniteta protiv psećeg adenovirusa tip 2 nije utvrđeno izazivanjem imunološkog odgovora.
English: The live attenuated virus vaccine strains CAV-2, CPiV and CPV-2b may be shed by vaccinated dogs following vaccination, shedding of CPV has been shown for up to 10 days.
Croatian: Živo atenuirano virusno cjepivo sojeva CAV-2, CPiV i CPV-2b može biti izlučeno od strane cijepljenih pasa nakon cijepljenja, izlučivanje CPV-a zamijećeno je unutar 10 dana.
English: Once mixed, the contents of the vial should appear a pink/red or yellowish colour with a slight opalescence.
Croatian: Nakon miješanja sadržaj bočice bi trebao biti ružičasto crvene ili žućkaste boje s blagom opalescencijom.
English: Aseptically reconstitute the lyophilisate with the solvent.
Croatian: Aseptički rekonstituirati liofilizat s otapalom.
English: Lyophilisate and solvent for suspension for injection.
Croatian: Liofilizat i otapalo za suspenziju za injekciju.
English: Pharmacotherapeutic group: Immunologicals for canidae, live viral vaccines.
Croatian: FARMAKOLOŠKA IMUNOLOŠKA SVOJSTVA Farmakoterapijska grupa: imunološki pripravci za pse, živa virusna cjepiva.
English: STATEMENT OF ACTIVE SUBSTANCES Each dose of 1 ml contains:
Croatian: SASTAV DJELATNIH TVARI Svaka doza od 1 ml sadržava:
English: At least three years following the primary vaccination course for canine distemper virus, canine adenovirus type 1, canine adenovirus type 2 and canine parvovirus.
Croatian: Najmanje tri godine nakon osnovnog cijepljenja protiv virusa štenećaka, psećeg adenovirusa tip 1, psećeg adenovirusa tip 2 i psećeg parvovirusa.
English: Second dose: Versican Plus DHPPi mixed with Versiguard Rabies 3-4 weeks later, but not before 12 weeks of age.
Croatian: Druga doza: Versican Plus DHPPi pomiješan sa Versiguard Rabies 3 - 4 tjedna kasnije, ali ne prije navršenih 12 tjedana života.
English: Canine parvovirus Type 2b
Croatian: Pseći parvovirus tip 2b
English: Although the efficacy of the rabies fraction has been demonstrated following administration at 12 weeks, at the discretion of the veterinary surgeon, in case of need, dogs younger than 8 weeks can be vaccinated with Versican Plus DHPPi mixed with Versiguard Rabies as the safety of this association has been demonstrated in 6 week old dogs.
Croatian: Iako je učinkovitost frakcije bjesnoće dokazana 12 tjedana nakon primjene, po vlastitom nahođenju veterinara, a u slučaju potrebe, može se cijepiti pse mlađe od 8 tjedana, s Versican Plus DHPPi pomiješanim s Versiguard Rabies, jer je dokazana neškodljivost navedenog načina primjene u pasa u dobi od 6 tjedana.
English: Shake well and administer immediately the entire contents (1 ml) of the reconstituted product.
Croatian: Dobro promućkati i odmah primijeniti cijelu količinu (1
English: Canine adenovirus Type 2, strain CAV-2 Bio 13
Croatian: Pseći adenovirus tip 2, soj CAV-2 Bio 13
English: MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCES AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNE TVAR I PROIZVOĐAČ ODGOVORAN ZA PUŠTANJE SERIJE U PROMET
English: In situations where very high maternally derived antibody levels are expected, the vaccination protocol should be planned accordingly.
Croatian: Protokol cijepljenja treba biti planiran u skladu sa situacijama gdje se očekuje visoka razina majčinskih protutijela.
English: Lyophilisate: Trometamol Edetic acid Sucrose Dextran 70
Croatian: Trometamol EDTA - etilendiamintetraoctena kiselina
English: The contents of a single vial of Versican Plus DHPPi should be reconstituted with the contents of a single vial of Versiguard Rabies (instead of the solvent).
Croatian: Sadržaj jedne bočice Versican Plus DHPPi treba rekonstituirati sa sadržajem jedne bočice Versiguard Rabies (umjesto s otapalom).
English: Marketing authorisation holder:
Croatian: Nositelj odobrenja za stavljanje u promet:
English: Type I glass vial containing 1 dose of lyophilisate closed with a bromobutyl rubber stopper and aluminium cap.
Croatian: I sadržavaju 1 dozu otapala, zatvorene brombutilnim gumenim čepom i aluminijskom kapicom.
English: Canine parainfluenza Type 2 virus
Croatian: Pseći parainfluenca virus tip 2
English: 6.5 Nature and composition of immediate packaging
Croatian: 6.5 Osobine i sastav unutarnjeg pakovanja Staklene bočice tipa
English: It was shown that 3 years after the vaccination CAV-2 antibodies are still present.
Croatian: Pokazalo se da su 3 godine nakon cijepljenja protiv psećeg adenovirusa tip 2, protutijela još uvijek prisutna.
English: Canine parvovirus Type 2b, strain CPV-2b Bio 12/B
Croatian: Pseći parvovirus tip 2b, soj CPV-2b-Bio 12/B 10
English: PACKAGE LEAFLET: Versican Plus DHPPi lyophilisate and solvent for suspension for injection for dogs
Croatian: UPUTA O VMP: Versican Plus DHPPi liofilizat i otapalo za suspenziju za injekciju za pse
English: Reconstituted vaccine: whitish to yellowish colour with a slight opalescence.
Croatian: Rekonstituirano cjepivo: bjelkasta do žućkasta boja s blagom opalescencijom.
English: − to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus.
Croatian: - sprječavanje kliničkih znakova, leukopenije, izlučivanja virusa uzrokovanog psećim parvovirusom, - sprječavanje kliničkih znakova (nazalnog i očnog iscjetka) i smanjenje izlučivanja virusa uzrokovanog psećim parainfluenca virusom.
English: Once mixed, the contents of the vial should appear a whitish to yellowish colour with a slight opalescence.
Croatian: Nakon miješanja sadržaj bočice bi trebao biti bjelkaste do žućkaste boje s blagom opalescencijom.
English: 4.9 Amounts to be administered and administration route
Croatian: 4.9 Količine koje se primjenjuju i put primjene Subkutana upotreba.
English: Revaccination scheme:
Croatian: Docjepljivanje (revakcinacija):
English: Type I glass vial containing 1 ml of solvent closed with a chlorobutyl rubber stopper and aluminium cap.
Croatian: I sadržavaju 1 dozu liofilizata, zatvorene brombutilnim gumenim čepom i aluminijskom kapicom.